gainbot
BriefMoversScreensSectorsEarningsIPOsNewsDividends & splitsScreenerWatchlistLearn
NASDAQ · TCMDHealthcareSurgical Instruments

Tactile Systems Technology, Inc. (TCMD)

$27.18+9.69%
Close Nov 4, 2026 · split-adjusted
Nov 4, 2026$27.71▲ 75.71% in range
Nov 3, 2025Low $15.77 · High $33.05Nov 4, 2026
What changed · written from our data
As of Nov 4, 2026

Tactile Systems Technology closed at $27.18 on Nov 4, up 9.69%, 17.8% below its 52-week closing high. Volume of 861.9K shares was 4.23× its 20-day average (well above normal).

Split-adjusted performance: +22.5% over one month, +7.4% over six months, +72.4% over one year.

In the quarter ended Sep 30, 2026, revenue was $91.86M, up 7.1% from a year earlier, with a net margin of 7.8%.

Short interest was 2.8M shares at the Oct 15 settlement (12.8% of float, 13.1 days to cover).

Market cap$615.7M22.7M shares
Revenue · quarter$91.9M+7.1% YoY
Diluted EPS$0.31−13.9% YoY
P/E · TTM25.9×P/S 1.7×
Net margin7.8%Gross 76.7%
Dividend yieldNone
52-week range15.77 – 33.05−17.8% from high
Volume861.9K4.23× 20-day avg
Volatility · 60d37.4%Annualised
Short % of float12.8%13.1 days to cover
Net cash$90.0MCash $90.0M
Next earnings—Not scheduled
Split-adjusted performance
1W +13.7%1M +22.5%3M −5.8%6M +7.4%YTD −6.3%1Y +72.4%3Y +149.6%5Y −20.1%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Surgical Instruments

Percentile among 110 companies (100 = best)

6-month momentum59
Revenue growth46
Net margin73
Value (low P/E)57
Size64

Industry medians: 6-month return −4.0%, revenue growth +8.9%, net margin −8.2%, P/E 30.5×.

Short interest

Details →
Shares short2.8M−0.7% vs prior
Days to cover13.1Settled Oct 15
% of float12.8%
Short vol. 10d64.4%of daily volume

Closest peers by size in Surgical Instruments

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
TCMDTactile Systems Technology$27.18+9.69%+7.4%+7.1%7.8%25.9$615.7M
SGHTSight Sciences$9.68+2.76%+125.1%+19.5%−19.0%—$533.3MCompare
ANGOAngioDynamics$12.25+4.43%+10.9%+6.9%−8.8%—$515.2MCompare
DCTHDelcath Systems$14.82+2.92%+31.6%+20.6%9.2%966.6$514.2MCompare
RCELAvita Medical$16.32+6.46%+269.2%+17.8%−35.3%—$504.7MCompare
CERSCerus$2.42+3.21%−6.8%+6.3%−0.9%—$486.7MCompare
BVSBioventus$11.42+4.34%+4.6%+2.7%4.2%13.0$780.0MCompare
MDXGMiMedx Group$3.20−1.54%−12.6%−45.2%−13.9%—$467.0MCompare
NPCENeuropace$13.34+8.37%−26.4%+17.1%−27.2%—$457.9MCompare

News about Tactile Systems Technology

All news →
Tactile Systems: 3 Key Takeaways for Long-Term InvestorsThe Motley Fool · 1d ago▲ PositiveTactile Systems Technology (TCMD) Q3 Earnings Surpass EstimatesZacks Investment Research · 2d agoNeutralTactile Medical's Spending Outpaces Sales: Rapid Earnings ReactionThe Motley Fool · 2d ago▼ NegativeTactile Medical Strengthens Board of Directors with Appointment of Andrea PearsonGlobeNewswire Inc. · Mar 9, 2026▲ Positive

Quick answers

What does Tactile Systems Technology do?
Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases.
What is TCMD's market cap?
$615.69M, based on the Nov 4 close of $27.18.
What is TCMD's P/E ratio?
25.9× trailing-twelve-month earnings of $23.82M.
Does Tactile Systems Technology pay a dividend?
No regular cash dividend has been paid in the last year.
How much of TCMD is sold short?
2.8M shares, 12.8% of float, as of Oct 15, 2026.
What sector is TCMD in?
Healthcare, in the Surgical Instruments industry.

About Tactile Systems Technology

Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system, provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.

HQ: Minneapolis, MN1,086 employeesListed Jul 28, 2016tactilemedical.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology